CoChat

SUPRACHOROIDAL DRUG INFUSION FOR THE TREATMENT OF SEVERE SUBFOVEAL HARD EXUDATES

Rizzo, Stanislao, Ebert, Federica Genovesi, Bartolo, Emanuele Di, Barca, Francesco, Cresti, Federica, Augustin, Constanze, Augustin, Albert · 2012 · Retina
Cited by 32

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

PURPOSE: To evaluate the safety, feasibility, and preliminary efficacy of suprachoroidal drug delivery with a microcatheter for the treatment of severe subfoveal hard exudates (SHE) in retinal vasculopathies. Definitive treatments for SHE have not yet been identified and prognosis is unfavorable. METHODS: In this prospective, interventional pilot study, six eyes of six patients with central or branch retinal vein occlusion or diffuse diabetic macular edema accompanied by massive refractory SHE underwent a single treatment with bevacizumab and triamcinolone administered to the submacular suprachoroidal space via a microcatheter introduced at the pars plana and advanced posteriorly. The main outcome measures included best-corrected visual acuity, vascular leakage, macular thickness, extent of SHE, and complications. RESULTS: Mean follow-up was 12 months. Three eyes had central retinal vein occlusion, one had branch retinal vein occlusion, and two had chronic diabetic macular edema. Best-corrected visual acuity improved by ≥2 lines in 4 eyes and remained stable in 2 eyes. At 1 month to 2 months postprocedure, SHE was almost completely resolved in all eyes and macular edema was significantly reduced. There were no surgical or postoperative complications. CONCLUSION: Suprachoroidal infusion of drugs can be effective in reabsorbing massive SHE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/iae.0b013e3182278b0e

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment

    Olsen, T. W., Feng, X., Wabner, K., Conston, S. R., Sierra, D. H., Folden, D. V., Smith, M. E., & Cameron, J. D. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.045 · Cited by 171 · cited 1×

    “Determination of the dosage of triamcinolone and bevacizumab was based on the dose and volume of drug used for intravitreal administration of bevacizumab or triamcinolone in other studies and previous investigations of the administration of drugs to the suprachoroidal space.(12) Main outcome measures were best-correct…”
    Method

Show all 1 references

Research works printed but not linked: 32

  1. Bresnick, 1983, Diabetic maculopathy: a critical review highlighting diffuse macular edema., Ophthalmology, 90, 1301, 10.1016/S0161-6420(83)34388-8 · doi:10.1016/s0161-6420(83)34388-8
  2. Otani, 2001, Tomographic findings of foveal hard exudates in diabetic macular edema., Am J Ophthalmol, 131, 50, 10.1016/S0002-9394(00)00661-9 · doi:10.1016/s0002-9394(00)00661-9
  3. 1993, Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus., N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
  4. 1998, Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)., Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  5. Do, 2005, . Persistent diabetic macular edema is associated with elevated hemoglobin A1C., Am J Ophthalmol, 139, 620, 10.1016/j.ajo.2004.10.063 · doi:10.1016/j.ajo.2004.10.063
  6. Deak, 2010, . Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography., Ophthalmology, 117, 773, 10.1016/j.ophtha.2009.09.027 · doi:10.1016/j.ophtha.2009.09.027
  7. Ciardella, 2004, . Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study., Br J Ophthalmol, 88, 1131, 10.1136/bjo.2004.041707 · DOI
  8. Martidis, 2002, . Intravitreal triamcinolone for refractory diabetic macular edema., Ophthalmology, 109, 920, 10.1016/S0161-6420(02)00975-2 · DOI · Paper page
  9. Avci, 2006, Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates., Graefes Arch Clin Exp Ophthalmol, 244, 28, 10.1007/s00417-005-0069-5 · DOI
  10. Dahr, 2007, Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina., Retina, 27, 150, 10.1097/IAE.0b013e318030a290 · DOI
  11. Zhu, 2008, . Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization., Ophthalmology, 115, 1750, 10.1016/j.ophtha.2008.04.023 · DOI
  12. Beer, 2003, . Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection., Ophthalmology, 110, 681, 10.1016/S0161-6420(02)01969-3 · DOI · Paper page
  13. Angulo Bocco, 2008, . Intravitreous injection: retrospective study of 2028 injections and their side effects., J Fr Ophtalmol, 31, 693, 10.1016/S0181-5512(08)74383-3 · doi:10.1016/s0181-5512(08)74383-3
  14. Wu, 2010, . Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months., Retina, 30, 1002, 10.1097/IAE.0b013e3181cea68d · DOI
  15. Yang, 2000, Surgical treatment for severe diabetic macular edema with massive hard exudates., Retina, 20, 121, 10.1097/00006982-200002000-00003 · doi:10.1097/00006982-200002000-00003
  16. Takagi, 1999, New surgical approach for removing massive foveal hard exudates in diabetic macular edema., Ophthalmology, 106, 249, 10.1016/S0161-6420(99)90054-4 · doi:10.1016/s0161-6420(99)90054-4
  17. Sakuraba, 2000, Visual improvement after removal of submacular exudates in patients with diabetic maculopathy., Ophthalmic Surg Lasers, 31, 287, 10.3928/1542-8877-20000701-06 · doi:10.3928/1542-8877-20000701-06
  18. Takaya, 2004, Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy., Retina, 24, 23, 10.1097/00006982-200402000-00004 · doi:10.1097/00006982-200402000-00004
  19. Naito, 2008, . Results of submacular surgery to remove diabetic submacular hard exudates., J Med Invest, 55, 211, 10.2152/jmi.55.211 · doi:10.2152/jmi.55.211
  20. Kim, 2007, . Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging., Invest Ophthalmol Vis Sci, 48, 808, 10.1167/iovs.06-0670 · DOI
  21. Entezari, 2005, . Posterior sub-Tenon triamcinolone for refractory diabetic macular edema: a randomized clinical trial., Eur J Ophthalmol, 15, 746, 10.1177/112067210501500614 · DOI
  22. Ip, 2009, . SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5., Arch Ophthalmol, 127, 1101, 10.1001/archophthalmol.2009.234 · DOI · Paper page
  23. Kinge, 2010, . Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study., Am J Ophthalmol, 150, 310, 10.1016/j.ajo.2010.03.028 · DOI
  24. Campochiaro, 2010, . Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes., Ophthalmology, 117, 2387, 10.1016/j.ophtha.2010.03.060 · doi:10.1016/j.ophtha.2010.03.060
  25. Sigurdsson, 1980, Organised macular plaques in exudative diabetic maculopathy., Br J Ophthalmol, 64, 392, 10.1136/bjo.64.6.392 · doi:10.1136/bjo.64.6.392
  26. Toussaint, 1962, Extravascular lesions of diabetic retinopathy., Arch Ophthalmol, 67, 42, 10.1001/archopht.1962.00960020044007 · doi:10.1001/archopht.1962.00960020044007
  27. Murata, 1992, Immunohistochemical detection of extravasated fibrinogen (fibrin) in human diabetic retina., Graefes Arch Clin Exp Ophthalmol, 30, 428, 10.1007/BF00175927 · doi:10.1007/bf00175927
  28. Vinores, 1989, Immunohistochemical localization of blood-retinal barrier breakdown in human diabetes., Am J Pathol, 134, 231
  29. 1985, Photocoagulation for diabetic macular edema. Early treatment of diabetic retinopathy study report number 1., Arch Ophthalmol, 103, 1796, 10.1001/archopht.1985.01050120030015 · DOI · Paper page
  30. Ferris, 1984, Macular edema: a complication of diabetic retinopathy., Surv Ophthalmol, 28, 452, 10.1016/0039-6257(84)90227-3 · DOI · Paper page
  31. Fong, 1997, . Subretinal fibrosis in diabetic macular edema. ETDRS report no. 23., Arch Ophthalmol, 115, 873, 10.1001/archopht.1997.01100160043006 · doi:10.1001/archopht.1997.01100160043006
  32. Avci, 2008, Long-term results of excision of plaque-like foveal hard exudates in patients with chronic diabetic macular oedema., Eye, 22, 1099, 10.1038/sj.eye.6702877 · doi:10.1038/sj.eye.6702877

Cited by

See all 32

Metadata

Authors
Rizzo, S., Ebert, F. G., Bartolo, E. D., Barca, F., Cresti, F., Augustin, C., & Augustin, A.
Venue
Retina
Published
2012-04
Volume
32
Issue
4
Pages
776-784
ISSN
0275-004X (ISSN-L)
OpenAlex
W1965713902
Cited by
32
References
1
FWCI
1.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SUPRACHOROIDAL DRUG INFUSION FOR THE TREATMENT OF SEVERE SUBFOVEAL HARD EXUDATES. https://app.cochat.ai/papers/10.1097/iae.0b013e3182278b0e
The paper
Rizzo, S., Ebert, F. G., Bartolo, E. D., Barca, F., Cresti, F., Augustin, C., & Augustin, A. (2012). SUPRACHOROIDAL DRUG INFUSION FOR THE TREATMENT OF SEVERE SUBFOVEAL HARD EXUDATES. Retina. https://doi.org/10.1097/iae.0b013e3182278b0e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.